109 related articles for article (PubMed ID: 1710778)
21. A normal ultrasound does not obviate the need for amniocentesis in patients with elevated serum alpha-fetoprotein.
Drugan A; Zador IE; Syner FN; Sokol RJ; Sacks AJ; Evans MI
Obstet Gynecol; 1988 Oct; 72(4):627-30. PubMed ID: 2458560
[TBL] [Abstract][Full Text] [Related]
22. [The usefulness of the level of alpha-fetoprotein (AFP) and electrophoresis of amniotic acetylcholinesterase for the detection of selected congenital malformations].
Lemonnier MC; Julian C; Aymé S; Philip N; Voeckel MA; Gamerre M; Mattéi JF
J Gynecol Obstet Biol Reprod (Paris); 1990; 19(3):280-4. PubMed ID: 1693158
[TBL] [Abstract][Full Text] [Related]
23. The importance of accurate gestational age estimation in screening for fetal neural tube defects using maternal serum alpha-fetoprotein levels.
Kirkpatrick A; Cohen M; Prescott GH; Jones OW; Matson M; Wepsic HT
UCLA Forum Med Sci; 1978; 20():199-205. PubMed ID: 80862
[TBL] [Abstract][Full Text] [Related]
24. Experience with a fetal dysmorphology/pathology service in an academic medical center.
Sharony R; Hixon H; Pepkowitz SH; Carlson DE; Platt LD; Graham JM
Birth Defects Orig Artic Ser; 1993; 29(1):219-33. PubMed ID: 8280875
[No Abstract] [Full Text] [Related]
25. Diagnostic use of meternal serum alpha-fetoprotein levels.
Cowchock FS; Jackson LG
Obstet Gynecol; 1976 Jan; 47(1):63-8. PubMed ID: 54892
[TBL] [Abstract][Full Text] [Related]
26. Maternal serum alpha-feto-protein: its value in antenatal diagnosis of genetic disease and in obstetrical-gynaecological care.
Habib ZA
Acta Obstet Gynecol Scand Suppl; 1977; 61():1-92. PubMed ID: 66853
[No Abstract] [Full Text] [Related]
27. Amniotic fluid alpha-fetoprotein levels in antenatal diagnosis of neural tube defects.
Johnson AM; Buchanan PD; Welt SI; Goodman HO; Christakos AC; Wiebe RH; Bishop EH; Aylsworth AS; Herrington RT
N C Med J; 1978 Feb; 39(2):98-100. PubMed ID: 75514
[No Abstract] [Full Text] [Related]
28. Effectiveness of combining maternal serum alpha-fetoprotein and hCG in a second-trimester screening program for Down syndrome.
Mooney RA; Peterson CJ; French CA; Saller DN; Arvan DA
Obstet Gynecol; 1994 Aug; 84(2):298-303. PubMed ID: 7518896
[TBL] [Abstract][Full Text] [Related]
29. [Determination of maternal serum alpha-fetoprotein levels].
Pejtsik B; Pácsa S; Wessely J; Kóbor J
Orv Hetil; 1981 Nov; 122(47):2883-5. PubMed ID: 6173827
[No Abstract] [Full Text] [Related]
30. [alpha-1 fetoprotein in the prenatal diagnosis of congenital developmental defects (author's transl1].
Bráza J; Zizkovský V; Koprivová H
Cas Lek Cesk; 1978 Jan; 117(3):76-80. PubMed ID: 75764
[No Abstract] [Full Text] [Related]
31. MULTISCAN--a Scandinavian multicenter second trimester obstetric ultrasound and serum screening study.
Jørgensen FS; Valentin L; Salvesen KA; Jørgensen C; Jensen FR; Bang J; Eik-Nes SH; Madsen M; Marsal K; Persson PH; Philip J; Bogstad JW; Nørgaard-Pedersen B
Acta Obstet Gynecol Scand; 1999 Jul; 78(6):501-10. PubMed ID: 10376859
[TBL] [Abstract][Full Text] [Related]
32. [Serum alpha-fetoprotein in pregnancy].
Thomsen SG; Lange AP; Isager-Sally L; Saurbrey N; Schiøler V
Ugeskr Laeger; 1985 Dec; 148(1):3-6. PubMed ID: 2420050
[No Abstract] [Full Text] [Related]
33. Second trimester maternal serum alpha-fetoprotein as an indicator of fetal risk.
Legge M; Duff GB; Pike L; Aickin DR
Aust N Z J Obstet Gynaecol; 1985 Nov; 25(4):266-8. PubMed ID: 2423067
[TBL] [Abstract][Full Text] [Related]
34. Maternal serum alpha-fetoprotein levels in congenital nephrotic syndrome carrier pregnancies.
Carrera M; Kestilä M; de la Iglesia C; Ruiz J; Serra B; Baraibar R
Prenat Diagn; 1999 May; 19(5):489-90. PubMed ID: 10360523
[No Abstract] [Full Text] [Related]
35. [Correlation between elevated maternal serum alpha-fetoprotein, certain pregnancy complications and fetal death].
Pejtsik B; Rappai G; Pintér J; Kelemen A
Orv Hetil; 1992 Oct; 133(41):2621-4. PubMed ID: 1383906
[TBL] [Abstract][Full Text] [Related]
36. [Significance of serum alpha fetoprotein and immunoglobulin G concentrations as a parameter of gestational-age examination in abnormalities and twins].
Stück B; Vajaradul C; Oberbeck F
Monatsschr Kinderheilkd (1902); 1975 May; 123(5):435-7. PubMed ID: 56706
[No Abstract] [Full Text] [Related]
37. Routine prenatal screening policy of fetal malformations by both maternal serum alpha-fetoprotein and ultrasound in eastern Hungary.
Szabó M; Tóth Z; Török O; Veress L; Bede E; Nagy E; Papp Z
Acta Chir Hung; 1989; 30(4):291-8. PubMed ID: 2484200
[TBL] [Abstract][Full Text] [Related]
38. Cautions about maternal serum alpha-fetoprotein screening.
Milunsky A; Haddow JE
N Engl J Med; 1985 Sep; 313(11):694. PubMed ID: 2410789
[No Abstract] [Full Text] [Related]
39. Prenatal serum alpha-fetoprotein screening for neural tube defects.
Macri JN; Weiss RR
Obstet Gynecol; 1982 May; 59(5):633-9. PubMed ID: 6175932
[TBL] [Abstract][Full Text] [Related]
40. Routine amniotic fluid alphafetoprotein assay: experience with 40,000 pregnancies.
Crandall BF; Matsumoto M
Am J Med Genet; 1986 May; 24(1):143-9. PubMed ID: 2422932
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
